Shenzhen Anlu Medical Technology Co., Ltd. (hereinafter referred to as "Anlu Medical") was listed in the 2022 Shenzhen High-Growth Enterprise TOP100 list, with its innovation capability and scale growth of 82.70% and 81.44%, respectively.
Anlu Medical is an innovative R&D and manufacturing company specializing in rapid in vitro diagnostic equipment and reagents for the animal field. It aims to provide rapid in vitro diagnostic solutions for pet hospitals by using pet medical care as the first entry point and leveraging its independent innovative technologies and integrated innovation capabilities.
Anlu Medical has developed the AI-100vet spherical component analyzer through technological innovation, which is the only original product that achieves multiple functions in one machine.
The AI-100vet combines cell biology, biochemistry, optics, and microscopic imaging technology with new technologies such as artificial intelligence, liquid staining, microfluidics, and automation. It revolutionarily enables a single test to simultaneously perform functions such as cell quantification, classification, counting, morphological recognition, and image display, bringing classic technologies into the era of automation, intelligence, and visualization.
On August 11, Li Yaping, Executive Vice President and Secretary-General of the Shenzhen Enterprise Evaluation Association, Niu Tao, President of the Shahe Branch of the Bank of China, and a delegation from the association's secretariat visited Shenzhen Anlu Medical Technology Co., Ltd., aiming to better understand the company's development status and needs, and to help the company achieve high-quality development.
Following the association's presentation of the 2022 Shenzhen Top 100 High-Growth Enterprises Development Report, all parties engaged in in-depth discussions regarding Anlu Medical's development needs. During the exchange, Wang Zhiping, General Manager of Anlu Medical, raised concerns about the company's needs in areas such as financing, intellectual property protection, and industry-academia-research collaboration. The association pledged to allocate high-quality resources to empower Anlu Medical's stronger development. After the meeting, Chairman Li presented Shenzhen Anlu Medical Technology Co., Ltd. with the 2022 Shenzhen Top 100 High-Growth Enterprises Certificate.
Shenzhen Anlu Medical Technology Co., Ltd.
China's innovative R&D and manufacturing enterprise of rapid in vitro diagnostic equipment and reagents
Founded in 2020, Anlu Medical aims to become a global provider of next-generation intelligent solutions for pet medical testing and diagnosis. Anlu Medical boasts a research and development team integrating multiple technical fields such as cell morphology, biochemistry, microfluidics, optics, and artificial intelligence, focusing on the research and application of independently developed technologies. It also possesses strong integration and application transformation capabilities, promoting industry-academia-research collaboration to jointly develop "professional, easy-to-use, scenario-based" rapid in vitro diagnostic equipment and reagents based on user scenario insights and needs.
Anlu Medical is currently focusing on providing automated, intelligent, user-friendly, and integrated solutions for highly manual and specialized examinations in veterinary hospitals, such as animal blood cell analysis, fecal microscopy, urine microscopy, and ascites cell analysis, based on its "POCT-enabled intelligent microscopic imaging platform." This platform integrates liquid-based cell staining technology, microfluidics, optical microscopy, high-precision automation, and artificial intelligence recognition algorithms. It is a world-first, original, and innovative technology platform, accumulating a wealth of independent intellectual property rights.
Anlu Medical is committed to the mission of "medical technology benefiting all people" and the vision of "focusing on the field of animal diagnostic and treatment devices, driving innovation, achieving customer success, and sharing added value with customers". It adheres to the values of "upholding integrity and simplicity, seeking truth and innovation, benefiting others and helping oneself, and being good at learning and valuing morality". It firmly believes that technology + scenario = product, adheres to the concept of independent innovation and integrated innovation, and only makes products that customers can use and that are useful.